Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-11-07
Summary
The purpose of this study is to compare liquid and tablet buprenorphine formulations.
Conditions
- Heroin Dependence
Interventions
- DRUG
-
Buprenorphine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Walter Ling, M.D. · Friends Research Institute, Inc.
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000222 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Clinical Trial of Buprenorphine - 3
NCT00000207 ·Status: COMPLETED ·Phase: PHASE3
-
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Buprenorphine Dosing Interval - 5
NCT00000209 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase I - 3
NCT00000221 ·Status: COMPLETED ·Phase: PHASE1
-
Alternate-Day Buprenorphine Administration. Phase VI - 7
NCT00000225 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000223 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
NCT00552578 ·Status: TERMINATED ·Phase: PHASE4
-
Alternate Day Buprenorphine Administration, Phase IX - 14
NCT00000232 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Methadone/Buprenorphine Cross-Over Study - 4
NCT00000208 ·Status: COMPLETED ·Phase: PHASE2
-
Extended-release Pharmacotherapy for Opioid Use Disorder
NCT05164549 ·Status: COMPLETED ·Phase: PHASE3
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
NCT00000353 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase VIII - 9
NCT00000227 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
NCT06379984 ·Status: RECRUITING ·Phase: PHASE2
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
NCT00078117 ·Status: COMPLETED ·Phase: PHASE3
-
Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
NCT01259102 ·Status: COMPLETED ·Phase: PHASE1
-
Sublingual Buprenorphine for Chronic Pain
NCT00612287 ·Status: UNKNOWN ·Phase: PHASE2
-
Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
NCT03608696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2